Extensive Trial Monitoring Confirms Evrysdi Does Not Damage Vision & The Series "Boy Meets World" episode artwork

EPISODE · Dec 9, 2020 · 11 MIN

Extensive Trial Monitoring Confirms Evrysdi Does Not Damage Vision & The Series "Boy Meets World"

from The Spinal Muscular Atrophy Podcast with Kevin Schaefer · host SMA News Today

SMA News Today’s multimedia associate, Price Wooldridge, discusses how extensive trial monitoring confirms Evrysdi does not damage vision in children or adults with Spinal Muscular Atrophy (SMA).SMA News Today’s Forums Director, Kevin Schaefer, talks about how the series “Boy Meets World” impacted him, and the correlation between creativity and SMA.================================To learn more about Evrysdi, please visit www.ApprovedForSMA.com ================================To take part in our ongoing discussions regarding SMA, please visit www.smanewstoday.com/forums ================================For the most up-to-date information regarding SMA, please visit www.smanewstoday.com

Episode metadata supplied by the publisher feed · Published Dec 9, 2020

Embed this episode

Ready to play

Extensive Trial Monitoring Confirms Evrysdi Does Not Damage Vision & The Series "Boy Meets World"

0:00 11:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Spinal Muscular Atrophy Podcast with Kevin Schaefer?

This episode is 11 minutes long.

When was this The Spinal Muscular Atrophy Podcast with Kevin Schaefer episode published?

This episode was published on December 9, 2020.

Can I download this The Spinal Muscular Atrophy Podcast with Kevin Schaefer episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!